Page 29 - பல்கலைக்கழகம் மருத்துவமனை பேசல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New study helps understand molecular profile of tumors in cancer patients Researchers from the University Hospitals in Zurich and Basel, ETH Zurich, University of Zurich and the pharmaceutical company Roche have set out to improve cancer diagnostics by developing a platform of state-of-the-art molecular biology methods. The Tumor Profiler project aims to derive the comprehensive molecular profile of tumors in cancer patients, which has the potential to predict the efficacy of a host of new cancer medications. It will therefore make it possible to offer treating physicians personalized and improved therapy recommendations. Three years ago, the researchers began a large-scale clinical study involving 240 patients suffering from metastatic skin cancer (melanoma), metastatic ovarian cancer, or acute myeloid leukemia. The thorough investigation of these patients tumors provides the researchers with a comprehensive understanding of the cellular composition and biology of each tumor.

Mitch levesqueAndreas wickiViola heinzelmannEmily hendersonUniversity hospital zurichUniversity hospitals in zurichUniversity hospital baselUniversity of zurichUniversity hospitalsUniversity hospitalStudy corresponding authorTumor profilerGynecological oncologyCancer diagnosticsMolecular biologyOvarian cancer